Structures by: Aakeröy C. B.
Total: 489
3-((1-pyrazolyl)methyl)benzamide
C11H11N3O
New Journal of Chemistry (2007) 31, 12 2044
a=7.7873(5)Å b=8.1130(6)Å c=8.8400(6)Å
α=77.6614(13)° β=74.4604(13)° γ=68.3976(12)°
BS-3-93-4f 3-((3-bromo-2,4-dimethylpyrazol-1- yl)methyl)benzamide
C13H14N3OBr
New Journal of Chemistry (2007) 31, 12 2044
a=8.9062(12)Å b=11.6933(18)Å c=14.146(2)Å
α=73.396(10)° β=74.274(9)° γ=70.553(9)°
2-amino-4-methyl-6-(3-pyridyl)pyrimidine,4-nitrobenzoic acid
(C10H10N4)(C7H5NO4)
New Journal of Chemistry (2006) 30, 10 1452
a=6.8245(5)Å b=9.5538(7)Å c=12.6278(9)Å
α=77.174(4)° β=84.400(4)° γ=82.637(4)°
2-amino-4-(3-pyridyl)-6-methylpyrimidine, 4-hydroxybenzoic acid
(C10H10N4)(C7H6O3)
New Journal of Chemistry (2006) 30, 10 1452
a=8.3089(6)Å b=8.9991(7)Å c=11.1671(7)Å
α=85.733(4)° β=69.174(4)° γ=77.699(5)°
(2-amino-4-(6-methoxy-3-pyridyl)-6-methylpyrimidine), Me5-PhCOOH
(C11H12N4O)(C12H16O2)
New Journal of Chemistry (2006) 30, 10 1452
a=5.3534(5)Å b=12.6941(12)Å c=15.1880(14)Å
α=87.7550(10)° β=82.9210(10)° γ=87.542(2)°
1-(3-methoxy-5-pyridyl)-2-(2-amino-6-methyl-4-pyrimidyl)ethyne, (NO2)2PhCOOH
(C13H12N4O)(C7H4N2O6)
New Journal of Chemistry (2006) 30, 10 1452
a=7.374(11)Å b=8.385(13)Å c=17.56(3)Å
α=93.51(10)° β=96.29(7)° γ=104.50(11)°
[1-(3-OMe-5-pyridyl)-2-(2-amino-4-methyl-6-pyrimidyl)-ethyne], 3-Me2N-PhCOOH
(C13H12N4O)(C9H11NO2)
New Journal of Chemistry (2006) 30, 10 1452
a=10.5742(19)Å b=14.599(3)Å c=13.519(3)Å
α=90.00° β=102.453(11)° γ=90.00°
2-amino-4-(3-pyridyl)-6-methylpyrimidine, Me5-PhCOOH
(C10H10N4)(C12H16O2)
New Journal of Chemistry (2006) 30, 10 1452
a=8.2088(7)Å b=8.7891(6)Å c=15.3371(12)Å
α=92.767(5)° β=105.536(4)° γ=115.332(4)°
(2-amino-4-(6-methoxy-3-pyridyl)-6-methylpyrimidine), (2,4-difluorobenzoic acid)
(C11H12N4O),(C7H4F2O2)
New Journal of Chemistry (2006) 30, 10 1452
a=33.158(4)Å b=7.3848(7)Å c=14.1634(16)Å
α=90.00° β=106.439(6)° γ=90.00°
2-(4-pyridyl)-imidazole, silver(I) perchlorate
(C8H7N3)Ag(ClO4)(C2H3N)
New Journal of Chemistry (2013) 37, 1 204
a=6.9519(6)Å b=14.9904(13)Å c=12.8623(13)Å
α=90.00° β=103.276(6)° γ=90.00°
4-(2-imidazolyl)-pyridine, silver(I)
(C8H6N3)Ag
New Journal of Chemistry (2013) 37, 1 204
a=6.4496(5)Å b=13.5953(11)Å c=8.6168(6)Å
α=90.00° β=94.244(3)° γ=90.00°
4-(2-imidazolyl)-pyridine, silver(I) nitrate
(C8H7N3)4(AgNO3)4(H2O)3
New Journal of Chemistry (2013) 37, 1 204
a=6.9704(4)Å b=7.8319(5)Å c=19.4544(11)Å
α=79.749(2)° β=85.086(2)° γ=81.023(2)°
N,N,N',N'-tetraacetyl-a,a'-diamino-m-xylene
C16H20N2O4
CrystEngComm (2010) 12, 10 3218
a=14.3232(9)Å b=16.4424(11)Å c=13.4342(8)Å
α=90.00° β=101.320(3)° γ=90.00°
N,N,N',N'-tetraacetyl-alpha,alpha'-diamino-p-xylene
C16H20N2O4
CrystEngComm (2010) 12, 10 3218
a=12.5627(5)Å b=13.5463(4)Å c=9.3888(3)Å
α=90.00° β=95.444(2)° γ=90.00°
NAP-12 tetraacetyl 1,5-naphthalenediamine
C18H18N2O4
CrystEngComm (2010) 12, 10 3218
a=9.5245(6)Å b=10.3300(7)Å c=8.7471(6)Å
α=90.00° β=106.108(4)° γ=90.00°
N,N,N',N'-tetraacetyl 1,4-cyclohexanediamine
C14H22N2O4
CrystEngComm (2010) 12, 10 3218
a=12.3457(13)Å b=5.8212(6)Å c=10.0737(10)Å
α=90.00° β=107.176(7)° γ=90.00°
N,N,N',N'-tetraacetyl ethylenediamine
C10H16N2O4
CrystEngComm (2010) 12, 10 3218
a=5.9150(4)Å b=10.1956(7)Å c=9.1495(7)Å
α=90.00° β=96.388(5)° γ=90.00°
N,N,N',N'-tetraacetyl 1,4-diaminobutane Cu(OH2)2 (ClO4)2 (H2O)2
Cu(H2O)2(C12H20N2O4)(ClO4)2
CrystEngComm (2010) 12, 10 3218
a=7.3645(4)Å b=12.3273(7)Å c=11.7535(6)Å
α=90.00° β=100.600(3)° γ=90.00°
Tetraacetyl 1,4-butanediamine
C12H20N2O4
CrystEngComm (2010) 12, 10 3218
a=14.7246(15)Å b=11.3474(11)Å c=7.8352(8)Å
α=90.00° β=90.917(5)° γ=90.00°
N,N,N',N'-tetraacetyl-1,8-diaminooctane
C16H28N2O4
CrystEngComm (2010) 12, 10 3218
a=20.0183(5)Å b=4.54300(10)Å c=20.5970(5)Å
α=90.00° β=110.9860(10)° γ=90.00°
Zn(OH2)2 (Ac2N-(CH2)6-NAc2)
Zn(H2O)2(C14H24N2O4)(ClO4)2
CrystEngComm (2010) 12, 10 3218
a=20.223(3)Å b=7.9438(12)Å c=14.875(2)Å
α=90.00° β=97.797(9)° γ=90.00°
C11H10IN3O
C11H10IN3O
CrystEngComm (2019) 21, 40 6048
a=26.035(8)Å b=4.7746(16)Å c=9.927(4)Å
α=90° β=99.80(2)° γ=90°
C13H13N3,0.5(C2H2O4)
C13H13N3,0.5(C2H2O4)
CrystEngComm (2019) 21, 40 6048
a=10.478(3)Å b=10.115(3)Å c=13.052(4)Å
α=90° β=106.830(12)° γ=90°
C11H8IN3
C11H8IN3
CrystEngComm (2019) 21, 40 6048
a=4.4460(14)Å b=13.030(4)Å c=19.520(7)Å
α=90° β=90° γ=90°
C6H6CuIN2O
C6H6CuIN2O
Chemical Communications (2000) 11 935
a=13.495(3)Å b=4.1059(9)Å c=16.727(4)Å
α=90.00° β=109.626(4)° γ=90.00°
C6H6CuIN2O
C6H6CuIN2O
Chemical Communications (2000) 11 935
a=13.5444(13)Å b=4.1098(4)Å c=15.0940(14)Å
α=90.00° β=105.583(2)° γ=90.00°
JB-1-35 2,3,5,6-Me4-pyrazine-1,4-dioxide, [I-(CF2)6-I]2
(C8H12N2O2)(C6F12I2)2
Chemical communications (Cambridge, England) (2015) 51, 12 2425-2428
a=12.3893(14)Å b=12.6332(14)Å c=13.1553(14)Å
α=67.319(4)° β=75.273(4)° γ=67.884(4)°
TW-4py-der 1,1'-di[(4-pyridyl)methyl]-2,2'-biimidazole
C18H16N6
Chemical communications (Cambridge, England) (2015) 51, 12 2425-2428
a=5.1637(9)Å b=16.705(3)Å c=9.1021(16)Å
α=90.00° β=98.398(6)° γ=90.00°
TW-SC-2 2,3,5,6-Me4-pyrazine-1,4-dioxide, I-(CF2)2-I
(C8H12N2O2)(C2F4I2)
Chemical communications (Cambridge, England) (2015) 51, 12 2425-2428
a=8.6275(16)Å b=12.005(2)Å c=8.3466(15)Å
α=90.00° β=118.080(5)° γ=90.00°
JB-1-2 pyrazine 1-oxide, I-(CF2)4-I
(C4H4N2O)(C4F8I2)
Chemical communications (Cambridge, England) (2015) 51, 12 2425-2428
a=5.3515(5)Å b=11.1482(11)Å c=12.0159(12)Å
α=85.076(2)° β=80.408(3)° γ=84.424(2)°
JB-1-34 2,3,5,6-Me4-pyrazine-1,4-dioxide, I-(CF2)4-I
(C8H12N2O2)(C4F8I2)
Chemical communications (Cambridge, England) (2015) 51, 12 2425-2428
a=9.3817(10)Å b=12.8620(14)Å c=8.1127(9)Å
α=90.00° β=110.521(3)° γ=90.00°
Isonicotinamide, I2
(C6H6N2O)(I2)
Chemical Communications (Cambridge, United Kingdom) (2007) 41 4236-4238
a=7.6928(10)Å b=7.7411(10)Å c=8.1841(11)Å
α=80.734(2)° β=72.131(2)° γ=85.702(2)°
2(C6H6N2O),C6F4I2
2(C6H6N2O),C6F4I2
Chemical Communications (Cambridge, United Kingdom) (2007) 41 4236-4238
a=20.247(3)Å b=5.0710(9)Å c=21.279(3)Å
α=90.00° β=106.911(6)° γ=90.00°
Bis[N-(3-pyridyl)acetamide], 1,4-diiodotetrafluorobenzene
(C7H8N2O)2(C6F4I2)
CrystEngComm (2008) 10, 12 1816
a=4.2616(9)Å b=29.232(6)Å c=17.734(4)Å
α=90.00° β=90.860(4)° γ=90.00°
2-(4-pyridyl)benzimidazole, 1,4-diiodotetrafluorobenzene, methanol
(C12H9N3)(C6F4I2)(CH4O)
CrystEngComm (2008) 10, 12 1816
a=9.0808(7)Å b=16.3144(12)Å c=13.6934(9)Å
α=90.00° β=91.057(4)° γ=90.00°
Bis{N-[(3-pyridyl)methyl]acetamide}, 1,4-diiodotetrafluorobenzene
(C8H10N2O)2(C6F4I2)
CrystEngComm (2008) 10, 12 1816
a=4.845(2)Å b=9.716(4)Å c=13.075(6)Å
α=104.096(6)° β=98.360(6)° γ=91.246(6)°
4-(pyrazol-3-yl)pyridine, 1,4-diiodotetrafluorobenzene
(C8H7N3)(C6F4I2)
CrystEngComm (2008) 10, 12 1816
a=7.1917(5)Å b=24.644(2)Å c=8.7269(7)Å
α=90.00° β=100.535(5)° γ=90.00°
[(5-OMe-3-pyridyl)(3-pyridyl)ethyne]4, [1,4-I2-F4-benzene]4
(C13H10N2O)4(C6F4I2)3
CrystEngComm (2008) 10, 12 1816
a=7.6881(4)Å b=14.8996(8)Å c=15.3296(8)Å
α=72.1600(10)° β=88.3640(10)° γ=88.5080(10)°
(pyridine-3,5-COOH) (2-AcNH-pyr)2, (1,4-I2-F4-benzene)2
(C7H5NO4)(C7H8N2O)2(C6F4I2)2
CrystEngComm (2008) 10, 12 1816
a=30.345(2)Å b=4.1878(3)Å c=16.6946(12)Å
α=90.00° β=90.00° γ=90.00°
(5-methoxy-3,3'-bipyridyl)2, (1,4-diiodotetrafluorobenzene)3
(C11H10N2O)2(C6F4I2)3
CrystEngComm (2008) 10, 12 1816
a=7.2012(7)Å b=17.6878(15)Å c=17.7138(16)Å
α=89.927(4)° β=82.869(7)° γ=88.275(6)°
(4-bromo-PhC(CN)(=NOH)), 3-bromo-5-methoxypyridine
(C8H5BrN2O)(C6H6BrNO)
CrystEngComm (2009) 11, 3 439-443
a=6.9907(6)Å b=8.0552(7)Å c=15.3027(13)Å
α=79.305(5)° β=89.038(5)° γ=64.660(5)°
(4-bromo-PhC(CN)(=NOH)), 1-(4-bromobenzyl)-2- methylbenzimidazole
(C8H5BrN2O)(C15H13BrN2)
CrystEngComm (2009) 11, 3 439-443
a=4.9374(6)Å b=22.597(3)Å c=19.233(2)Å
α=90.00° β=96.869(2)° γ=90.00°
(4-bromo-PhC(CN)(=NOH)), 1-(4-bromobenzyl)benzimidazole
(C8H5BrN2O)(C14H11BrN2)
CrystEngComm (2009) 11, 3 439-443
a=5.3033(6)Å b=13.2294(15)Å c=15.0601(17)Å
α=102.536(2)° β=99.505(2)° γ=94.752(2)°
(2-fluoro-PhC(CN)(=NOH))2, 1,2-di(4-pyridyl)ethene
(C8H5N2OF)2(C12H10N2)
CrystEngComm (2009) 11, 3 439-443
a=3.8189(6)Å b=11.2941(18)Å c=14.107(2)Å
α=98.884(10)° β=93.147(11)° γ=94.624(10)°
481 1,4-di((1-benzimidazolyl)methyl)benzene, (3-chloro- PhC(CN)(=NOH))2
(C22H18N4)(C8H5N2OCl)2
CrystEngComm (2009) 11, 3 439-443
a=13.6335(10)Å b=4.4402(3)Å c=27.297(2)Å
α=90.00° β=94.084(3)° γ=90.00°
MS 512 1-(4-pyridylmethyl)-5,6-Me2benzimidazole, 4-F- PhC(CN)(NOH)
(C15H15N3)(C8H5N2OF)
CrystEngComm (2009) 11, 3 439-443
a=16.1659(12)Å b=6.4146(5)Å c=21.0074(16)Å
α=90.00° β=105.945(5)° γ=90.00°
1,4-bis((1-pyrazolyl)methyl)benzene, (3,5-dinitrobenzoic acid)2
(C14H14N4)(C7H4N2O6)2
CrystEngComm (2006) 8, 8 586
a=12.526(3)Å b=10.179(2)Å c=12.332(3)Å
α=90.00° β=115.038(4)° γ=90.00°
MF142Me8 1,4-bis((3,5-dimethylpyrazol-1-yl)methyl)benzene, (2,6-Cl2PhCOOH)2
(C18H22N4)(C7H4Cl2O2)2
CrystEngComm (2006) 8, 8 586
a=7.5783(8)Å b=7.9010(9)Å c=14.1442(13)Å
α=103.784(7)° β=101.429(7)° γ=90.509(6)°
MF142Me8 1,4-bis((3,5-dimethylpyrazol-1-yl)methyl)benzene (Me5-PhCOOH)2
(C18H22N4)(C12H16O2)2
CrystEngComm (2006) 8, 8 586
a=8.8093(6)Å b=14.7493(10)Å c=15.4238(12)Å
α=67.222(4)° β=82.777(4)° γ=86.232(4)°
2-(4-(dimethylamino)phenylazo)benzoic acid, 3,5- dinitrobenzoic acid
(C15H15N3O2)(C7H4N2O6)
CrystEngComm (2004) 6, 5 19-24
a=7.0051(5)Å b=8.6187(7)Å c=18.5866(15)Å
α=101.186(2)° β=97.114(2)° γ=101.401(2)°
3-nitrobenzoic acid, isonicotinamide
(C7H5NO4)(C6H6N2O)
CrystEngComm (2004) 6, 5 19-24
a=5.9827(4)Å b=9.1713(8)Å c=12.1893(8)Å
α=84.149(5)° β=77.407(6)° γ=74.927(5)°
Isonicotinamide, 4-fluorobenzoic acid
(C6H6N2O)(C7H5FO2)
CrystEngComm (2004) 6, 5 19-24
a=22.725(13)Å b=5.231(3)Å c=20.785(12)Å
α=90.00° β=95.402(11)° γ=90.00°
4-nitrobenzoic acid, 3-(dimethylamino)benzoic acid
(C7H5NO4)(C9H11NO2)
CrystEngComm (2004) 6, 5 19-24
a=7.1538(13)Å b=7.9978(15)Å c=14.315(3)Å
α=91.111(3)° β=91.483(4)° γ=111.582(3)°
3,5-dinitrobenzamide, 4-(dimethylamino)benzoic acid
(C7H5N3O5)(C9H11NO2)
CrystEngComm (2004) 6, 5 19-24
a=8.0266(14)Å b=8.5974(16)Å c=12.514(2)Å
α=84.563(3)° β=89.934(4)° γ=75.345(3)°
AR-ZZ4 pentyl 4-pyridyl cavitand, 1,4-I2-F4-benzene
(C72H76N4O8)(C6F4I2)2(C2H3N)2
CrystEngComm (2012) 14, 20 6366
a=12.3175(5)Å b=13.2596(6)Å c=25.4769(11)Å
α=88.893(2)° β=88.152(2)° γ=79.980(2)°
C159H160.5F16I4N9.5O16
C159H160.5F16I4N9.5O16
CrystEngComm (2012) 14, 20 6366
a=18.758(3)Å b=19.828(3)Å c=22.558(3)Å
α=100.106(10)° β=98.682(10)° γ=110.342(9)°
Pyrazinecarboxamide, 4-nitrobenzamide
(C5H5N3O)(C7H6N2O3)
CrystEngComm (2004) 6, 5 19-24
a=7.6155(7)Å b=7.6980(9)Å c=21.587(2)Å
α=95.590(8)° β=94.719(7)° γ=90.268(8)°
Bis(N-(3-pyridyl)acetamide) fumaric acid
(C7H8N2O)2(C4H4O4)
CrystEngComm (2007) 9, 1 46
a=17.930(4)Å b=3.9380(10)Å c=25.723(6)Å
α=90.00° β=90.00° γ=90.00°
N-(4-pyridyl)acetamide, glutaric acid
(C7H8N2O)(C5H8O4)
CrystEngComm (2007) 9, 1 46
a=7.1730(8)Å b=7.6117(8)Å c=11.9194(13)Å
α=80.462(7)° β=75.807(7)° γ=87.896(7)°
(N-((4-pyridyl)methyl)acetamide)2, fumaric acid
(C8H10N2O)2(C4H4O4)
CrystEngComm (2007) 9, 1 46
a=4.9718(10)Å b=7.0047(11)Å c=15.101(2)Å
α=77.032(10)° β=89.414(12)° γ=82.324(12)°
N-(4-pyridyl)acetamide, sebacic acid
(C7H8N2O)2(C10H18O4)
CrystEngComm (2007) 9, 1 46
a=28.532(3)Å b=8.2965(8)Å c=10.6120(10)Å
α=90.00° β=101.987(2)° γ=90.00°
4-(acetamidomethyl)pyridine, adipic acid
(C8H10N2O)2(C6H10O4)
CrystEngComm (2007) 9, 1 46
a=4.7523(7)Å b=24.295(3)Å c=10.0355(12)Å
α=90.00° β=97.944(10)° γ=90.00°
(4-(aminomethyl)pyridine acetate)2, isophthalic acid
(C8H6O4)(C8H10N2O)2
CrystEngComm (2007) 9, 1 46
a=34.784(6)Å b=57.476(12)Å c=4.7674(9)Å
α=90.00° β=90.00° γ=90.00°
N-(4-pyridylmethyl)acetamide, 5-nitroisophthalic acid hydrate
(C8H10N2O)(C8H5NO6)(H2O)
CrystEngComm (2007) 9, 1 46
a=18.5868(12)Å b=6.8213(5)Å c=14.0335(10)Å
α=90.00° β=103.406(4)° γ=90.00°
P50 2-aminopyrazine, (4-NO2-PhCOOH)2
(C4H5N3)(C7H5NO4)2
CrystEngComm (2012) 14, 18 5845
a=13.8994(7)Å b=5.4845(3)Å c=13.1317(6)Å
α=90.00° β=101.948(2)° γ=90.00°
P55 2-aminopyrazine, 3-NO2-PhCOOH
(C4H5N3)(C7H5NO4)2
CrystEngComm (2012) 14, 18 5845
a=5.9930(10)Å b=12.1894(18)Å c=12.995(2)Å
α=90.00° β=98.803(8)° γ=90.00°
P54 2-aminopyrazine, 3,5-(NO2)2-PhCOOH
(C4H5N3)(C7H4N2O6)
CrystEngComm (2012) 14, 18 5845
a=7.6755(11)Å b=8.8822(11)Å c=9.6107(15)Å
α=84.645(10)° β=82.063(11)° γ=74.877(10)°
D3 2-aminopyrazine, HOOC-(CH2)2-COOH
(C4H5N3)2(C4H6O4)
CrystEngComm (2012) 14, 18 5845
a=5.3982(9)Å b=19.505(3)Å c=6.9524(12)Å
α=90.00° β=104.487(10)° γ=90.00°
D9 2-aminopyrazine, HOOC-(CH2)5-COOH
(C4H5N3)(C7H12O4)
CrystEngComm (2012) 14, 18 5845
a=5.0231(5)Å b=34.308(3)Å c=7.4377(8)Å
α=90.00° β=102.850(5)° γ=90.00°
D4 2-aminopyrazine, HOOC-(CH2)8-COOH
(C4H5N3)(C10H18O4)
CrystEngComm (2012) 14, 18 5845
a=5.7935(6)Å b=7.5090(8)Å c=8.7271(8)Å
α=92.984(4)° β=91.952(5)° γ=98.570(5)°
D5 2-aminopyrazine, HOOC-(CH2)6-COOH
(C4H5N3)(C8H14O4)
CrystEngComm (2012) 14, 18 5845
a=7.7749(5)Å b=9.8014(7)Å c=9.2097(6)Å
α=90.00° β=101.560(3)° γ=90.00°
P13 2,6-Br2-3-NH2-pyrazine, 2,5-(HO)2-PhCOOH
(C4H3N3Br2)(C7H6O4)
CrystEngComm (2012) 14, 18 5845
a=6.8754(7)Å b=7.1197(7)Å c=13.8665(14)Å
α=87.951(3)° β=86.435(3)° γ=72.915(4)°
AR-cc-2c-10 2,6-dibromo-3-aminopyrazine, F5-PhCOOH
(C4H3N3Br2)(C7HF5O2)
CrystEngComm (2012) 14, 18 5845
a=15.5511(6)Å b=5.8057(2)Å c=16.0859(6)Å
α=90.00° β=111.0750(10)° γ=90.00°
P9 2-amino-3,5-dibromopyrazine, 3,5-(NO2)2-PhCOOH
(C4H3N3Br2)(C7H4N2O6)
CrystEngComm (2012) 14, 18 5845
a=7.3153(3)Å b=10.4607(4)Å c=10.8371(4)Å
α=65.094(2)° β=83.688(2)° γ=89.742(2)°
ARcc-2c-7 2-amino-3,5-dibromopyrazine, 2,6-difluorobenzoic acid
(C4H3N3Br2)(C7H4O2F2)
CrystEngComm (2012) 14, 18 5845
a=5.6663(5)Å b=13.2299(11)Å c=17.3426(14)Å
α=90.00° β=93.911(4)° γ=90.00°
1-(4-pyridyl)-2-(2,3,5,6-F4-4-I-phenyl)ethene
(C13H6F4NI)
CrystEngComm (2007) 9, 5 421
a=12.0266(5)Å b=10.2443(4)Å c=4.9988(2)Å
α=90.00° β=90.00° γ=90.00°
N7 Cu(F6-acac)2 (1-(4-pyridyl)-2-(2,3,5,6-F4-4-Br- phenyl)ethene)2
Cu(C5HO2F6)2(C13H6F4NBr)2
CrystEngComm (2007) 9, 5 421
a=8.9889(3)Å b=9.0836(3)Å c=12.9622(5)Å
α=88.061(2)° β=86.489(2)° γ=67.894(2)°
NSBrCo Co(F6-acac)2 (1-(4-pyridyl)-2-(2,3,5,6-F4-4-Br- phenyl)ethene)2
Co(C5HO2F6)2(C13H6F4NBr)2
CrystEngComm (2007) 9, 5 421
a=8.9245(4)Å b=9.0077(3)Å c=13.0921(5)Å
α=86.370(2)° β=86.442(2)° γ=70.214(2)°
N3 Cu(F6-acac)2 (1-(4-pyridyl)-2-(2,3,5,6-F4-4-I- phenyl)ethene)2
Cu(C5HO2F6)2(C13H6F4NI)2
CrystEngComm (2007) 9, 5 421
a=9.0352(4)Å b=9.0357(4)Å c=13.2174(6)Å
α=87.447(2)° β=88.530(2)° γ=69.506(2)°
Tetra-(3-pyridyl)ethynyl calixarene
(C80H76N4O8)(C2H3N)(H2O)2
CrystEngComm (2006) 8, 7 502
a=25.359(2)Å b=22.2099(19)Å c=12.1129(10)Å
α=90.00° β=90.00° γ=90.00°
Hexyl bromo calixarene, acetonitrile
(C52H60O8I4)(C2H3N)
CrystEngComm (2006) 8, 7 502
a=19.045(3)Å b=16.627(2)Å c=18.618(3)Å
α=90.00° β=118.047(8)° γ=90.00°
SF228 (3-pyridyl)-CONH-N=CH-(2-pyridyl), 3-fluorobenzoic acid
(C12H10N4O)(C7H5FO2)(H2O)
CrystEngComm (2012) 14, 7 2435
a=6.6065(14)Å b=7.2295(17)Å c=21.354(4)Å
α=92.457(13)° β=97.668(14)° γ=116.706(15)°
SF229 (3-pyridyl)-CONH-N=CH-(2-pyridyl), 4-nitrobenzoic acid hydrate
(C12H10N4O)(C7H5NO4)(H2O)
CrystEngComm (2012) 14, 7 2435
a=6.5983(13)Å b=7.2343(14)Å c=19.755(4)Å
α=81.922(11)° β=84.772(14)° γ=80.711(16)°
SF807 [(4-pyridyl)-CONH-N=CH-(4-pyridyl)], hexanedioic acid hydrate
(C12H10N4O)(C6H10O4)(H2O)
CrystEngComm (2012) 14, 7 2435
a=6.8908(3)Å b=11.3841(6)Å c=12.6504(6)Å
α=66.395(2)° β=89.086(2)° γ=84.907(2)°
SF40 4-pyridyl-CONH-N=CH-4-pyridyl, octanedioic acid hydrate
(C12H10N4O)(C8H14O4)(H2O)
CrystEngComm (2012) 14, 7 2435
a=6.918(2)Å b=11.800(4)Å c=13.910(5)Å
α=67.522(16)° β=79.851(16)° γ=84.973(16)°
SF355 4-pyridyl-CONH-N=CH-2-pyridyl, 2,4-difluorobenzoic acid hydrate
(C12H10N4O)(C7H4O2F2)(H2O)(O0.1)
CrystEngComm (2012) 14, 7 2435
a=7.4376(2)Å b=12.3798(4)Å c=39.3480(11)Å
α=90.00° β=93.396(2)° γ=90.00°
SF363 [4-pyridyl-CONH-N=CH-2-pyridyl] adipic acid
(C12H10N4O)2(C6H10O4)(H2O)2
CrystEngComm (2012) 14, 7 2435
a=6.6047(8)Å b=8.0678(9)Å c=15.3573(18)Å
α=98.182(6)° β=101.688(8)° γ=104.436(9)°
SF241 formylpyridine phenylhydrazone, octanoic acid, hydrate
(C12H10N4O)(C8H16O2)(H2O)
CrystEngComm (2012) 14, 7 2435
a=6.6610(8)Å b=8.4541(11)Å c=19.684(2)Å
α=99.459(8)° β=94.349(9)° γ=107.887(8)°
SF357 [(3-pyridyl)-CONH-N=CH-(2-pyridyl)]2, octanedioic acid hydrate
(C12H10N4O)2(C8H14O4)(H2O)2
CrystEngComm (2012) 14, 7 2435
a=6.6074(6)Å b=8.1545(7)Å c=15.8735(14)Å
α=81.488(6)° β=83.679(6)° γ=75.024(7)°
SF 356 (4-pyridyl)-CONH-N=CH-(2-pyridyl), decanedioic acid
(C12H10N4O)2(C10H18O4)(H2O)2
CrystEngComm (2012) 14, 7 2435
a=6.5516(4)Å b=8.1666(5)Å c=33.7458(19)Å
α=94.293(3)° β=93.041(3)° γ=105.225(3)°
C20 (4-pyridyl)-CONH-N=CH-(2-pyridyl), 4-aminobenzoic acid hydrate ?
(C12H10N4O)(C7H7NO2)(H2O)
CrystEngComm (2012) 14, 7 2435
a=8.8995(2)Å b=14.6202(4)Å c=14.0267(3)Å
α=90.00° β=93.198(2)° γ=90.00°
3,3'-AzoPy-3HBXB (3-pyridyl)-N=N-(3-pyridyl), (4-I-F4-PhOH)2
(C10H8N4)(C6HF4IO)2
CrystEngComm (2013) 15, 16 3125
a=19.0228(11)Å b=16.8636(10)Å c=7.2425(4)Å
α=90.00° β=93.198(2)° γ=90.00°
3,3'-AzoPy 2-HBXB (3-pyridyl)-N=N-(3-pyridyl), (4-Br-F4- PhCOOH)2
(C10H8N4)(C7HBrF4O2)2
CrystEngComm (2013) 15, 16 3125
a=4.8724(3)Å b=22.0007(13)Å c=11.6936(7)Å
α=90.00° β=101.336(3)° γ=90.00°
3,3'-AzoPy 1-HB-XB (3-pyridyl)-N=N-(3-pyridyl), (4-I-F4- PhCOOH)2
(C10H8N4)(C7HF4IO2)2
CrystEngComm (2013) 15, 16 3125
a=4.9020(3)Å b=21.4561(12)Å c=12.1298(7)Å
α=90.00° β=100.151(2)° γ=90.00°
3,3'-AzoPy 8-HBXB (3-pyridyl)-N=N-(3-pyridyl), (4-I-F4- PhCH=NOH)2
(C10H8N4)(C7H2F4INO)2
CrystEngComm (2013) 15, 16 3125
a=5.6341(4)Å b=10.4834(7)Å c=11.5197(8)Å
α=75.365(2)° β=77.562(2)° γ=80.975(2)°
4,4'-AzoPy 1-HB-XB (4-pyridyl)-N=N-(4-pyridyl), (4-I-F4- PhCOOH)
(C10H8N4)(C7HF4IO2)
CrystEngComm (2013) 15, 16 3125
a=6.2112(8)Å b=8.1879(11)Å c=8.9824(12)Å
α=84.843(3)° β=70.837(3)° γ=77.402(3)°
4,4'-AzoPy 3-HBXB (4-pyridyl)-N=N-(4-pyridyl), 4-I-F4-PhOH
(C10H8N4)(C6HF4IO)
CrystEngComm (2013) 15, 16 3125
a=6.1515(5)Å b=9.8197(7)Å c=13.7443(10)Å
α=81.558(3)° β=85.932(3)° γ=78.342(3)°
4,4'-AzoPy 8HBXB (4-pyridyl)-N=N-(4-pyridyl), 4-I-F4-PhCHO oxime
(C10H8N4)(C7H2F4INO)
CrystEngComm (2013) 15, 16 3125
a=17.6282(7)Å b=6.3167(3)Å c=31.7318(14)Å
α=90.00° β=96.518(2)° γ=90.00°
4,4'AzoPy 5-HBXB (4-pyridyl)-N=N-(4-pyridyl), (4-Br-F4-PhCHO oxime)2
(C10H8N4)(C7H2BrF4NO)2
CrystEngComm (2013) 15, 16 3125
a=10.2846(10)Å b=4.6215(5)Å c=27.841(2)Å
α=90.00° β=98.246(6)° γ=90.00°
3,3'-AzoPy-SA (3-pyridyl)-N=N-(3-pyridyl), HOOC-(CH2)2-COOH
(C10H8N4)(C4H6O4)
CrystEngComm (2013) 15, 3 463
a=11.9092(7)Å b=5.2342(3)Å c=11.3589(7)Å
α=90.00° β=91.198(3)° γ=90.00°